Skip to main content

Viridian Therapeutics Inc(VRDN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low27.85
Day High28.95
Open:28.19
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Viridian Therapeutics Inc

Select a category then submit the form to load news
Tipranks
Truist Financial Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Crescent Biopharma (CBIO) and Viridian Therapeutics (VRDN)
Tipranks
Analysts’ Top Healthcare Picks: Heron Therapeutics (HRTX), Viridian Therapeutics (VRDN)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Delcath Systems (DCTH), Viridian Therapeutics (VRDN)
Motley Fool
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake
Tipranks
Analysts Offer Insights on Healthcare Companies: Glaukos (GKOS), Viridian Therapeutics (VRDN) and Atricure (ATRC)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viridian Therapeutics (VRDN), Biodesix (BDSX) and Staar Surgical (STAA)
Tipranks
Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Sarepta Therapeutics (SRPT) and Viridian Therapeutics (VRDN)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Demant (OtherWILLF), Viridian Therapeutics (VRDN) and Tenet Healthcare (THC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Viridian Therapeutics (VRDN) and Enovis (ENOV)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA) and Viridian Therapeutics (VRDN)
Tipranks
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Viridian Therapeutics (VRDN)
Motley Fool
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock?
Tipranks
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST)
Tipranks
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Sanofi (OtherSNYNF)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Viridian Therapeutics (VRDN)
Tipranks
Viridian Therapeutics (VRDN) Receives a Buy from Wedbush
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Viridian Therapeutics (VRDN), Fortrea Holdings Inc. (FTRE) and Cytokinetics (CYTK)
Tipranks
Evercore ISI Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)
Tipranks
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Viridian Therapeutics (VRDN) and OmniAb (OABI)
Tipranks
Wedbush Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)
Tipranks
Truist Financial Initiates a Buy Rating on Viridian Therapeutics (VRDN)
Tipranks
H.C. Wainwright Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)
Tipranks
Viridian Therapeutics Advances Toward Profitability with Strategic Moves
Business Wire
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tipranks
H.C. Wainwright Keeps Their Buy Rating on Viridian Therapeutics (VRDN)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Sarepta Therapeutics (SRPT), Castle Biosciences (CSTL) and Viridian Therapeutics (VRDN)
Business Wire
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Business Wire
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
Tipranks
Viridian Therapeutics’ Promising Phase 3 Trial for Thyroid Eye Disease
Tipranks
Viridian Therapeutics Advances VRDN-003 Study for Thyroid Eye Disease
Tipranks
Viridian Therapeutics Announces Stock Sale Agreement

Profile

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.